Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials

Authors :: Pagano, L.
Pulsoni, Alessandro
Tosti, M. E.
Caramatti, C.
Cerri, R.
Falcucci, P.
Fazi, P.
Fianchi, L.
Martino, B.
Mattei, D.
Offidani, M.
Pacilli, L.
Pogliani, E. M.
Rotoli, B.
Specchia, G.
Visani, G.
Vignetti, Marco
Voso, M. T.
Leone, G.
Mandelli, Franco
Gimema
Pagano, L
Pulsoni, A
Tosti, M
Caramatti, C
Cerri, R
Falcucci, P
Fazi, P
Fianchi, L
Martino, B
Mattei, D
Offidani, M
Pacilli, L
Pogliani, E
Rotoli, B
Specchia, G
Visani, G
Vignetti, M
Voso, M
Leone, G
Mandelli, F
Publication Year :: 2004
Abstract: Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials

Subjects :: Male
Adult
Cancer Research
Pediatrics
medicine.medical_specialty
Adolescent
antineoplastic combined chemotherapy protocols
neoplasms
Acute Disease
Aged
Antineoplastic Combined Chemotherapy Protocols
Cohort Studies
Female
Humans
Leukemia, Myeloid
Middle Aged
Neoplasms, Second Primary
Remission Induction
Treatment Failure
Treatment failure
Remission induction
cohort studies
hemic and lymphatic diseases
medicine
humans
Antineoplastic Combined Chemotherapy Protocol
Adult patients
acute disease
adolescent
adult
adverse effects
aged
chemically induced
drug therapy
female
leukemia
male
middle aged
myeloid
remission induction
second primary
treatment failure
business.industry
Adult Acute Myeloid Leukemia
Hematology
Oncology
Second Malignancy
Cohort Studie
business
Settore MED/15 - Malattie del Sangue
After treatment
Cohort study
Human

Tools